Turtle 🐢 Cyte ! What else can we see under the microscope? Credit to #Ghazi_Speaks on Facebook! #PathTwitter #MatchToPath #MedStudentTwitter #Pathology #pathology #Path2Path

A delicious gelato 🌹🍦 to celebrate another year of life + the daily effort of giving my best as I train to become a #renal #pathologist at @MGBpathology by day & striving to be the best mom I can be by night. Both challenging but filled with joy, purpose, & fulfillment 🔬♥️✨

🔎Happening at 10:30am today during #ASCyto26! @MauroSaieg leads Companion Session 6: Cytopathology Practice in Latin America — Current Status and Future Directions

Review his classic work on preanalytic specimen triage here:
acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

#CytoPath

This is going to be fun! Tune in to find out about the doctor you didn’t know you had. I’ll discuss why and how you can meet your pathologist. Thank you @outcomes4me
Register here us02web.zoom.us/webinar/regist…

Breast mass in 45/F with p63 IHC. How will you sign out? #breastpath

ABPath certified its first class of 60 Diplomates in 1936. Certification exams looked very different in the decades that followed—including the 1972 exam pictured here, administered in a hotel ballroom.

Explore 90 years of history: bit.ly/4fgdapu

To all the #Pathology PGY-1s:
Congratulations on the start of an incredible journey 🎉

Stay curious, keep asking questions, and seek knowledge every day. Wishing you all the very best as you begin this exciting chapter! ❤️
#PathTwitter #MedTwitter #PathX #PathResident

Please fill out this 2 minute survey to help develop future terminology for peritoneal fluids for TIS 2.0
Your input is needed to appropriately categorize benign and borderline tumor cellular elements seen in peritoneal fluids #CytoPath #cytology

tinyurl.com/4sxejcz5

From the booth at #ASCO26, I spoke with Dr. Marilyn Bui of @MoffittNews, about her work in pathology, biomarker testing and AI.

Her expertise in digital pathology and augmented intelligence is helping support more precise cancer diagnosis and treatment planning for patients.
#ASCO26 #MoffittASCO26

The @FDA has recently approved trastuzumab deruxtecan (T-DXd, Enhertu) for treating early-stage, #HER2-positive #breastcancer based on two clinical trials, one of which was led by MSK breast medical oncologist Dr. Shanu Modi.

“HER2-positive breast cancer is an aggressive diagnosed at an early stage,” Dr. Modi says. “This approval will change the way that many patients with this type of breast cancer are treated and offer the chance for more patients to be cured.”

A drug had already transformed care for metastatic HER2-positive and HER2-low breast cancer.

Learn more about this approval: bit.ly/4e8HLVm

True medical mysteries, revealed from the shadows.
A young man with recurring pain.
No explanation. Cultures negative. The doctors, baffled.

So a pathologist steps in.
The truth was hiding … in an everyday habit.
Listen now: podcast.ausha.co/case-encounter…

This is going to be great! Leadership is not easy, and these topics are not discussed enough. Check it out! #pathology #pathtwitter #pathX

Great news for @UTMDAnderson patients. This rapid assay from FNA supernatants is now validated for clinical testing 🙌🏽
One day TAT for NGS 🧬 + save tissue for IHC 🔬= Win for everyone #CytoPath #MolDx #liquidbiopsy
@lungoncdoc @DrMCabanillas @DrAManiakas @MehmetAltanMD

Grateful to be presenting our work at #AACR2026 and reconnecting with outstanding mentors along the way.

A special highlight was meeting with Dr. Singh, former USA Health Research Director.
Thanks to all the mentors and colleagues for the guidance and support. @PathologyUSAH ne #Pathology #ResearchJourney

Sometimes the answer isn’t more resources—it’s using what you have better.
Join our FREE 3-part webinar on lab quality management. Strengthen systems, teams & processes.
📅 Starts April 21, 12 PM CT
🔗 Register
register.gotowebinar.com/register/70359…
@Baskotacytopath @IPathC @path_overseas

Blooming season in Indiana — and in #Pathology. 🌼 🌸

Ready to share how @iupathology and @IURadiology are Reimagining #DiagnosticMedicine for the @IndianaPath Spring Seminar. I’ll be using illustrative #BreastPath and #GYNPath examples to make my case!

Absolutely thrilled to share this exciting announcement 📣 is this mic on…

It’s time to dust off my graduation regalia and celebrate the science graduates 🎓
nothing beats the music of Pomp and Circumstance🎶
Time to write my speech!
#GoGreen @MSUnews @MSUNatSci
#PathX

I just learned today that ocular #melanomas are more likely to have GNAQ (and GNA11) as the primary driver mutations.

#derm
#pathX
#dermpath

Usual ductal hyperplasia with focal central necrosis? Just by morphology no stains performed. Not very common but let me know if you agree or disagree #pathtwitter #pathX #breastpath

Apocrine lesions are tough. What would be your top line in this apocrine lesion?
A) Atypical apocrine adenosis
B) Apocrine DCIS- I think too much architecture complexity
C) My Diagnosis
#breastpath

Reflections of Spring #NYC
4.16.2026 #urbanpalette 🎨